kabutan

YOMEISHU SEIZO CO.,LTD.(2540) Summary

2540
TSE Prime
YOMEISHU SEIZO CO.,LTD.
4,405
JPY
-25
(-0.56%)
Dec 5, 12:30 pm JST
28.39
USD
Dec 4, 10:30 pm EST
Result
PTS
outside of trading hours
4,407
Dec 5, 12:33 pm JST
Summary Chart Historical News Financial Result
PER
72.7
PBR
1.28
Yield
1.02%
Margin Trading Ratio
38.77
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
4,400 JPY 28.36 USD
Previous Close Dec 4
4,430 JPY 28.51 USD
High Dec 5, 9:43 am
4,420 JPY 28.49 USD
Low Dec 5, 9:07 am
4,370 JPY 28.16 USD
Volume
3,900
Trading Value
0.02B JPY 0.11M USD
VWAP
4398.46 JPY 28.35 USD
Minimum Trading Value
440,500 JPY 2,839 USD
Market Cap
0.07T JPY 0.47B USD
Number of Trades
27
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
116
1-Year High Mar 25, 2025
775
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 8,800 401,500 45.63
Nov 21, 2025 9,300 398,500 42.85
Nov 14, 2025 8,800 396,800 45.09
Nov 7, 2025 10,500 378,700 36.07
Oct 31, 2025 12,200 375,400 30.77
Company Profile
YOMEISHU SEIZO CO.,LTD. is the leading manufacturer of medicinal liquor, established in 1602. The company develops the "Yomeishu" brand. Its largest shareholder is Taisho Pharmaceutical.
Sector
Foods
YOMEISHU SEIZO CO.,LTD. primarily engages in the manufacturing and sales of "Yomeishu" and other alcoholic beverages and food products both domestically and internationally. Additionally, the company operates solar power generation for electricity sales, real estate leasing, and restaurant management. In the Yomeishu-related business, the company manufactures and sells alcoholic beverages and food products, including its flagship product "Yomeishu," in Japan and overseas. The company has also positioned its related businesses under the concept of "Expanding the Circle of Healthy Living," which it calls the "Kurasowa" business. This includes multi-faceted retail and service operations such as store management in directly-operated commercial facilities, restaurant management, mail-order sales, and external sales through other companies' distribution channels. YOMEISHU SEIZO CO.,LTD. is an equity-method affiliate of Taisho Pharmaceutical Holdings.